COVID-19 should be a methylene blue "promoter"

Braz J Cardiovasc Surg. 2020 Aug 1;35(4):604-605. doi: 10.21470/1678-9741-1-2020-0607.
No abstract available

Publication types

  • Letter

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections / drug therapy*
  • Humans
  • Methylene Blue / therapeutic use*
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • SARS-CoV-2

Substances

  • Methylene Blue